Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Feng R, Su Q, Huang X, Basnet T, Xu X, Ye W. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun (Lond). 2023;43(1):75–86.

Article  PubMed  Google Scholar 

Huang J, Lucero-Prisno DE 3rd, Zhang L, Xu W, Wong SH, Ng SC, Wong MCS. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20(5):271–87.

Article  PubMed  Google Scholar 

Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Klümpen HJ, Adeva J, Vogel A, Lleo A, Fabris L, Ponz-Sarvise M, Brustia R, Cardinale V, Braconi C, Vidili G, Jamieson NB, Macias RI, Jonas JP, Marzioni M, Hołówko W, Folseraas T, Kupčinskas J, Sparchez Z, Krawczyk M, Krupa Ł, Scripcariu V, Grazi GL, Landa-Magdalena A, Ijzermans JN, Evert K, Erdmann JI, López-López F, Saborowski A, Scheiter A, Santos-Laso A, Carpino G, Andersen JB, Marin JJ, Alvaro D, Bujanda L, Forner A, Valle JW, Koerkamp BG, Banales JM. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol. 2022;76(5):1109–21.

Article  CAS  PubMed  Google Scholar 

Fernandes E, Sores J, Cotton S, Peixoto A, Ferreira D, Freitas R, Reis CA, Santos LL, Ferreira JA. Esophageal, gastric and colorectal cancers: looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology. Theranostics. 2020;10(11):4903–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol. 2020;21(12):729–49.

Article  CAS  PubMed  Google Scholar 

Verhelst X, Dias AM, Colombel J-F, Vermeire S, Van Vlierberghe H, Callewaert N, Pinho SS. Protein glycosylation as a diagnostic and prognostic marker of Chronic Inflammatory Gastrointestinal and Liver diseases. Gastroenterology. 2020;158(1):95–110.

Article  CAS  PubMed  Google Scholar 

Thomas D, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188464.

Article  CAS  PubMed  Google Scholar 

Stanley P. Genetics of glycosylation in mammalian development and disease. Nat Rev Genet. 2024;25(10):715–29.

CAS  PubMed  Google Scholar 

Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17(10):597–617.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2024;14(3):1098–110.

Article  CAS  PubMed  Google Scholar 

Takahashi S, Sugiyama T, Shimomura M, Kamada Y, Fujita K, Nonomura N, Miyoshi E, Nakano M. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer. Glycoconj J. 2016;33(3):471–82.

Article  CAS  PubMed  Google Scholar 

Liu P, Wang X, Dun A, Li Y, Li H, Wang L, Zhang Y, Li C, Zhang J, Zhang X, Ma L, Hou H. High-throughput profiling of Serological Immunoglobulin G N-Glycome as a noninvasive biomarker of gastrointestinal cancers. Engineering. 2023;26:44–53.

Article  CAS  Google Scholar 

Ren S, Zhang Z, Xu C, Guo L, Lu R, Sun Y, Guo J, Qin R, Qin W, Gu J. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types. Cell Res. 2016;26(8):963–6.

Article  PubMed  PubMed Central  Google Scholar 

Zhao YP, Ruan CP, Wang H, Hu ZQ, Fang M, Gu X, Ji J, Zhao JY, Gao CF. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. Cancer. 2012;118(3):639–50.

Article  CAS  PubMed  Google Scholar 

Pan Y, Zhang L, Zhang R, Han J, Qin W, Gu Y, Sha J, Xu X, Feng Y, Ren Z, Dai J, Huang B, Ren S, Gu J. Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning. Am J Cancer Res. 2021;11(6):3002–20.

CAS  PubMed  PubMed Central  Google Scholar 

Gu Y, Duan B, Sha J, Zhang R, Fan J, Xu X, Zhao H, Niu X, Geng Z, Gu J, Huang B, Ren S. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer. Int J Cancer. 2023;152(3):536–47.

Article  CAS  PubMed  Google Scholar 

Mechref Y, Hussein A, Bekesova S, Pungpapong V, Zhang M, Dobrolecki LE, Hickey RJ, Hammoud ZT, Novotny MV. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res. 2009;8(6):2656–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan H, Wu Z, Zhang H, Zhang J, Liu Y, Li Z, Feng W, Wang G, Liu Y, Zhao D, Zhang Z, Liu Y, Zhang Z, Liu X, Tao L, Luo Y, Wang X, Yang X, Zhang F, Li X, Guo X. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma. Front Immunol. 2023;14:981861.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ozcan S, Barkauskas DA, Renee Ruhaak L, Torres J, Cooke CL, An HJ, Hua S, Williams CC, Dimapasoc LM, Han Kim J, Camorlinga-Ponce M, Rocke D, Lebrilla CB, Solnick JV. Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila). 2014;7(2):226–35.

Article  CAS  PubMed  Google Scholar 

Demirhan DB, Yılmaz H, Erol H, Kayili HM, Salih B. Prediction of gastric cancer by machine learning integrated with mass spectrometry-based N-glycomics. Analyst. 2023;148(9):2073–80.

Article  CAS  PubMed  Google Scholar 

Zhao J, Qin R, Chen H, Yang Y, Qin W, Han J, Wang X, Ren S, Sun Y, Gu J. A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer. Clin Proteom. 2020;17:34.

Article  CAS  Google Scholar 

He K, Baniasad M, Kwon H, Caval T, Xu G, Lebrilla C, Hommes DW, Bertozzi C. Decoding the glycoproteome: a new frontier for biomarker discovery in cancer. J Hematol Oncol. 2024;17(1):12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ladabaum U, Mannalithara A, Weng Y, Schoen RE, Dominitz JA, Desai M, Lieberman D. Comparative effectiveness and cost-effectiveness of Colorectal Cancer Screening with blood-based biomarkers (Liquid Biopsy) vs fecal tests or Colonoscopy. Gastroenterology. 2024;167(2):378–91.

Article  CAS  PubMed  Google Scholar 

Pongracz T, Mayboroda OA, Wuhrer M. The human blood N-Glycome: unraveling Disease glycosylation patterns. JACS Au; 2024.

Verhelst X, Geerts A, Callewaert N, Van Vlierberghe H. The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation. Acta Gastroenterol Belg. 2019;82(2):309–13.

CAS  PubMed  Google Scholar 

Wang Y, Liu Y, Liu S, Cheng L, Liu X. Recent advances in N-glycan biomarker discovery among human diseases. Acta Biochim Biophys Sin (Shanghai). 2024;56(8):1156–71.

CAS  PubMed  Google Scholar 

Huang C, Fang M, Feng H, Liu L, Li Y, Xu X, Wang H, Wang Y, Tong L, Zhou L, Gao C. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: a large-scale multicenter study. Int J Cancer. 2021;149(3):717–27.

Article  CAS  PubMed  Google Scholar 

Qin R, Zhao J, Qin W, Zhang Z, Zhao R, Han J, Yang Y, Li L, Wang X, Ren S, Sun Y, Gu J. Discovery of non-invasive glycan biomarkers for detection and surveillance of gastric Cancer. J Cancer. 2017;8(10):1908–16.

Article  PubMed  PubMed Central  Google Scholar 

Shubhakar A, Jansen BC, Adams AT, Reiding KR, Ventham NT, Kalla R, Bergemalm D, Urbanowicz PA, Gardner RA, Wuhrer M, Halfvarson J, Satsangi J, Fernandes DL, Spencer DIR. Serum N-Glycomic biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease. J Crohns Colitis. 2023;17(6):919–32.

Article  PubMed